Skip to main content

Table 2 Paenibacillus sp. strain VT 400 CFU in the lungs and spleen 48 h post infection

From: Genomic characterization and assessment of the virulence and antibiotic resistance of the novel species Paenibacillus sp. strain VT-400, a potentially pathogenic bacterium in the oral cavity of patients with hematological malignancies

Dose (log10 CFU/mouse)

Log10 CFU/g tissue, mean ± SD

Lung

Spleen

Control

0

0

7.5

0.58 ± 0.28

0.14 ± 0.25

8.5

1.13 ± 0.55

0.25 ± 0.18

9.5

3.05 ± 0.74

1.20 ± 0.34